Epidermal growth factor receptor tyrosine kinase - Globe Thesis

Keyword [Epidermal growth factor receptor tyrosine kinase] Result: 101 - 117 \| Page: 6 of 6
101.	Correlation Between Expression Of PLOD2 And Acquired Resistance Of The First Generation Of EGFR-TKI In Advanced Lung Adenocarcinoma
102.	Analysis Of Prognostic Factors For 205 Patients Of Stage Ⅳ Lung Adenocarcinoma With EGFR Mutation Treated By EGFR-TKI Combined With Radiotherapy
103.	The Impact Of Cocurrent Alterations On EGFR-TKIs Efficacy And Progression Patterns After Drug Resistance In Advanced EGFR-mutant NSCLC Patients
104.	Non-invasive Prediction Models Of EGFR Mutation And TKI Efficacy In Non-small Cell Lung Cancer
105.	The Role And Molecular Mechanism Of MiR-29b-3p In EGFR-TKI Acquired Resistance By Targeting "PTEN/PI3K/Akt" Cascade In Lung Cancer
106.	Treatment Of Advanced EGFR-mutant Non-small-cell Lung Cancer:A Single-center Experience
107.	Study On The Mechanism Of Qilian Mixture Regulating Intestinal Flora And Improving The Curative Effect Of EGFR-TKI In Lung Adenocarcinoma Based On The Theory Of "Spleen As The Guard"
108.	Prognostic Analysis And Prediction Of Acquired Drug Resistance Subtypes In Patients With Lung Adenocarcinoma Treated With EGFR-TKI Based On Artificial Intelligence
109.	Yi-Fei San-Jie Pill Reverses Resistance To Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors In Non-Small Cell Lung Cancer By Modulating MET-associated MiR-335-5p
110.	Design,Synthesis And Biological Evaluation Ofindole Carboxamide Derivatives And Analogs
111.	The Design,Synthesis And Application Of The Fourth Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
112.	Efficacy And Safety Analyses Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Combined With Chemotherapy In Advanced Non–small-cell Lung Cancer With An EGFR/TP53 Co-mutation
113.	A Preliminary Observation Of The Changing Trend Of CtDNA In Patients Receiving EGFR-TKI Adjuvant Therapy For Lung Adenocarcinoma
114.	Comparative Efficacy And Safety Of First-line Treatments For Epidermal Growth Factor Receptor Mutation-positive Advanced Non-small Cell Lung Cancer
115.	Clinical Analysis Of Different Therapeutic Modes Of TKI Combined With SRS In The Treatment Of Lung Adenocarcinoma Patients With EGFR Sensitive Mutation And Primary Brain Metastasis
116.	Experimental Study Of Aumolertinib Combined With Radiation Therapy In EGFR-mutated NSCLC Brain Metastases Tumor
117.	Prognostic Analysis Of Adjuvant Targeted Therapy For EGFR-positive ⅠA Stage Invasive Lung Adenocarcinoma After Complete Resection
<<First <Prev Next> Last>> Jump to